REM-422 clinical trials

Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

This study is testing a new medicine, REM-422, for people with a type of cancer called Adenoid Cystic Carcinoma (ACC) that has come back, spread, or can't be removed by surgery. We want to see if it's safe and helps shrink the cancer.